NSF board member resigns, saying Trump’s policies have harmed the agency
By Jeffrey Mervis,
Science
| 05. 13. 2025
“Alondra Nelson” by Sage Ross on Wikimedia Commons
licensed under CC by SA 2.0
In an unprecedented move, a member of the governing body for the National Science Foundation (NSF) resigned today, saying the presidentially appointed advisory board has become a “ceremonial assemblage … without consequence” during the first months of President Donald Trump’s administration.
Sociologist Alondra Nelson was appointed to the National Science Board (NSB) in the final months of former President Joe Biden’s administration, where she had served as acting director of the White House Office of Science and Technology Policy before returning to the Institute for Advanced Study in 2023. Her departure, which she announced this morning in an essay in Time, is believed to be the first time in the agency’s 75-year history that a member of the 24-person board resigned over a policy disagreement with an administration.
“The board should have been far more communicative—with both congressional leaders and the American public—about the changes occurring at NSF,” Nelson tells Science. “Even if these actions were taken without the board’s input or consent, I...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...